Trials / Completed
CompletedNCT04634630
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung: a Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Beatrice Aramini · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The present study is a prospective cohort study. The aim is to assess the relationship between the presence of cancer stem-cells (CSC) and the risk of relapse in patients with early and locally advanced adenocarcinoma and squamous cell carcinoma of the lung
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Exposure to lung cancer stem cells | The exposure to lung cancer stem cells was measure as the percentage of Aldehyde dehydrogenase (ALDH) on all viable cells extracted from surgically resected tumor specimens |
Timeline
- Start date
- 2017-10-17
- Primary completion
- 2020-10-17
- Completion
- 2020-10-17
- First posted
- 2020-11-18
- Last updated
- 2021-06-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04634630. Inclusion in this directory is not an endorsement.